42 Conducting feasibility studies for others on the use of supercritical fluids in the formulation of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products; licensing of supercritical fluid technology; developing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products for others using supercritical fluid technology